How should I manage a patient with eosinophilia and suspected cellulitis who has not yet started antibiotics?

Management of Eosinophilia with Suspected Cellulitis (Pre-Antibiotic)

Do not start antibiotics immediately—obtain a skin biopsy first to rule out Wells' syndrome (eosinophilic cellulitis), which mimics bacterial cellulitis but requires corticosteroids, not antibiotics. 1, 2

Initial Diagnostic Approach

Key Clinical Features to Assess

• Presence of eosinophilia with cellulitis-like presentation should raise immediate suspicion for Wells' syndrome, particularly if the patient has a history of asthma or atopy 3, 2
• Look for pruritic (itchy) rather than tender lesions—bacterial cellulitis is typically painful, while Wells' syndrome is more pruritic 1
• Assess for bullae or blistering in addition to erythema and edema, which suggests eosinophilic cellulitis 1, 2
• Check if the patient is afebrile—Wells' syndrome patients are often afebrile despite impressive skin findings, whereas bacterial cellulitis typically presents with fever 1

Immediate Diagnostic Testing

• Obtain a complete blood count to quantify eosinophilia 2
• Perform skin biopsy before starting antibiotics—this is critical as histopathology showing dermal eosinophilic infiltration confirms Wells' syndrome and prevents unnecessary antibiotic use 1, 4, 2
• Order stool testing for ova and parasites, particularly if there is travel history to endemic regions, as helminth infections commonly cause eosinophilia 5

Travel History Considerations

If the patient has recent travel to tropical/subtropical regions or is a migrant:

• Consider helminth infections as the primary cause of eosinophilia 5
• Obtain concentrated stool microscopy, faecal PCR, and Strongyloides serology as these have good diagnostic yield across all travel regions 5
• For acute schistosomiasis (Katayama syndrome): Look for fever, cough, urticarial rash, and marked eosinophilia (sometimes >5 × 10⁹/L) occurring 2-8 weeks after freshwater exposure in Africa 5
• Exclude Loa loa before considering ivermectin treatment if the patient has traveled to endemic regions 5

Treatment Algorithm

If Wells' Syndrome is Confirmed or Highly Suspected

• Start systemic corticosteroids immediately—this is the most successful treatment with a 91.7% success rate 2
• Use prednisone 40 mg daily (or equivalent dose of methylprednisolone) 5, 2
• Expect rapid improvement within days of starting corticosteroids 1, 3
• Avoid antibiotics as they are ineffective and delay appropriate treatment 1, 3, 2

If Bacterial Cellulitis Cannot Be Excluded

Only if skin biopsy cannot be obtained immediately and clinical suspicion for bacterial infection remains high:

• For mild nonpurulent cellulitis: Use oral antibiotics targeting β-hemolytic streptococci—penicillin, amoxicillin, or cephalexin 5, 6
• For moderate to severe nonpurulent cellulitis: Use vancomycin plus piperacillin-tazobactam or imipenem/meropenem for broad coverage 5
• Duration of 5 days is recommended, but extend if no improvement 5
• However, if the patient fails to respond to appropriate antibiotics within 48-72 hours, immediately reconsider Wells' syndrome and obtain skin biopsy 2, 7

If Helminth Infection is Suspected

• For asymptomatic eosinophilia with negative stool microscopy: Consider empirical treatment with albendazole 400 mg single dose plus ivermectin 200 μg/kg single dose (after excluding Loa loa) 5
• For acute schistosomiasis: Empirical treatment is justified with the combination of eosinophilia, fever, and rash 2-8 weeks after freshwater exposure, even if serology is negative 5

Critical Pitfalls to Avoid

• Do not reflexively start antibiotics for all erythematous, edematous skin lesions with eosinophilia—this is the most common error leading to delayed diagnosis of Wells' syndrome 1, 3, 2
• Do not dismiss eosinophilia as incidental—it is a key diagnostic clue that should prompt consideration of non-infectious etiologies 2, 7
• Do not taper corticosteroids too rapidly in confirmed Wells' syndrome, as recurrence is common 3
• Do not give ivermectin without first excluding Loa loa in patients from endemic regions, as this can cause severe adverse reactions 5

Disposition Decisions

• Outpatient management is appropriate if the patient lacks systemic inflammatory response syndrome (SIRS), altered mental status, or hemodynamic instability 5
• Hospitalization is indicated for severe systemic symptoms, concern for necrotizing infection, immunocompromised status, or failure of outpatient therapy 5